Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release

Journal of Pharmaceutical Sciences

Volumn 85, Issue 7, 1996, Pages 732-740

  Gao, Ping ^a   Skoug, John W ^a   Nixon, Phillip R ^a   Ju, T Robert ^a   Stemm, Nick L ^a   Sung, Kuo Chun ^a,b  

^a PFIZER INC   (United States)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM MESILATE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE;

ANISOTROPY; ARTICLE; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GEL; MATHEMATICAL MODEL; MOLECULAR WEIGHT; PHARMACEUTICS; PHARMACOKINETICS; TABLET; VISCOSITY;

EID: 0030059152     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9504595     Document Type: Article

References (31)

1. Skoug, J. W.; Mikelsons, M. V.; Vigneron, C. N.; Stemm, N. L. J. Controlled Release 1993, 27, 227-245.
2. Skoug, J. W.; Borin, M. T.; Fleishaker, J. C.; Cooper, A. M. Pharm. Res. 1991, 8, 1282-1288.
3. Gao, P.; Fagerness, P. E. Pharm. Res. 1995, 12, 955-964.
4. Gao, P.; Nixon, P. R.; Skoug, J. W. Pharm. Res. 1995, 12, 965-971.
5. Huguchi, T. J. Pharm. Sci. 1963, 52, 1145-1149.
6. Gao, P.; Meury, R. H. J. Pharm. Sci. 1996, 85, 725-731.
7. Hogan, J. E. Drug Dev. Ind. Pharm. 1989, 15, 975-999.
8. Ford, J. L.; Rubinstein, R. H.; McCaul, F.; Hogan, J. E.; Edgar, P. J. Int. J. Pharm. 1987, 40, 223-234.
9. Mitchell, K.; Ford, J. L.; Armstrong, D. J.; Elliott, P. N. C.; Rostron, C.; Hogan, J. E. Int. J. Pharm. 1993, 100, 155-163.
10. Shah, C. N.; Zhang, G.; Apelian, V.; Zeng, F.; Infeld, M. H.; Malick, A. W. Pharm. Res. 1993, 10, 1693-1695.
11. Lee, P. I.; Peppas, N. A. J. Controlled Release 1987, 6, 207-215.
12. Ju, T. C. R.; Nixon, P. R., Patel, M. V. J. Pharm. Sci. 1995, 84, 1464-1477.
13. Ju, T. C. R.; Nixon, P. R.; Patel, M. V. J. Pharm. Sci. 1995, 84, 1455-1463.
14. Pham, A. T.; Lee, P. I. Pharm. Res. 1994, 11, 1379-1384.
15. Gao, P. Unpublished results.
16. Papadimitriou, E.; Buckton, G.; Efentakis, M. Int. J. Pharm. 1993, 98, 57-62.
17. Rajabi-Siahboomi, A. R.; Bowtell, R. W.; Mansfield, P.; Henderson, A.; Davies, M. C.; Melia, C. D. J. Controlled Release 1994, 31, 121-128.
18. Lee, P. I.; Kim, C. J. J. Membr. Sci. 1992, 65, 77-92.
19. Gehrke, S. H.; Biren, D.; Hopkins, J. J. J. Biomater. Sci., Polym. Ed. 1994, 6, 375-390.
20. Levine, I. N. Physical Chemistry, 3rd ed.; McGraw-Hill Book Company: New York, 1988; p 484.
21. Pitkin, C.; Carstensen, J. T. J. Pharm. Sci. 1973, 62, 1215.
22. Oksanen, C. A.; Zografi, G. Pharm. Res. 1993, 10, 791-799.
23. Galin, J. C.; Galin, M. J. Polym. Sci., Part B: Polym. Phys. 1995, 33, 2033-2043.
24. Merck Index, 11th ed.; Merck & Co.: Rahway, NJ, 1989; p 843.
25. Bettini, R.; Colombo, P.; Massimo, G.; Catellani, P. L.; Vitali, T. Eur. J. Pharm. Sci. 1994, 2, 213-219.
26. Mitchell, K.; Ford, J. L.; Armstrong, D. J.; Elliot, P. N. C.; Hogan, J. E.; Rostron, C. Int. J. Pharm. 1983, 100, 165-173.
27. Harland, R. S.; Gazzaniga, A.; Sangalli, M. E.; Colombo, P.; Peppas, N. Pharm. Res. 1988, 5, 488-494.
28. Lee, P. I. J. Membr. Sci. 1980, 7, 255-275.
29. Peppas, N. A. In Controlled Drug Bioavailability, Volume 1, Drug Product Design and Performance; Smolen, V. F., Ed.; Wiley: New York, 1984; Chapter 7.
30. Melia, C. D.; Rajabi-Siahboomi, A. R.; Davies, M. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 19th 1992, 28-29.
31. Colombo, P.; Bettini, R.; Massimo, G.; Catellani, P. L.; Santi, P.; Peppas, N. A. J. Pharm. Sci. 1995, 84, 991-996.